Skip to main content
Top
Published in: Annals of Hematology 4/2012

01-04-2012 | Letter to the Editor

Are int22h-mediated deletions a common cause of hemophilia?

Authors: Miguel Martín Abelleyro, Liliana Carmen Rossetti, Claudia Pamela Radic, Miguel Candela, Irene Beatriz Larripa, Carlos Daniel De Brasi

Published in: Annals of Hematology | Issue 4/2012

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
2.
3.
go back to reference Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, Ketterling RP, Kazazian HH Jr, Negrier C, Vinciguerra C, Gitschier J, Goossens M, Girodon E, Ghanem N, Plassa F, Lavergne JM, Vidaud M, Costa JM, Laurian Y, Lin S-W, Lin S-R, Shen M-C, Lillicrap D, Taylor SAM, Windsor S, Valleix SV, Nafa K, Sultan Y, Delpech M, Vnencak-Jones CL, Phillips JA, Ljung RCR, Koumbarelis E, Gialeraki A, Mandalaki T, Jenkins PV, Collins PW, Pasi KJ, Goodeve A, Peake I, Preston FE, Schwartz M, Scheibel E, Ingerslev J, Cooper DN, Millar DS, Kakkar VV, Giannelli F, Naylor JA, Tizzano EF, Baiget M, Domenech M, Altisent C, Tusell J, Beneyto M, Lorenzo JI, Gaucher C, Mazurier C, Peerlinck K, Matthijs G, Cassiman JJ, Vermylen J, Mori PG, Acquila M, Caprino D and lnaba H (1995) Factor VIII gene inversions in severe haemophilia A: results of an international consortium study. Blood 86:2206–2212PubMed Antonarakis SE, Rossiter JP, Young M, Horst J, de Moerloose P, Sommer SS, Ketterling RP, Kazazian HH Jr, Negrier C, Vinciguerra C, Gitschier J, Goossens M, Girodon E, Ghanem N, Plassa F, Lavergne JM, Vidaud M, Costa JM, Laurian Y, Lin S-W, Lin S-R, Shen M-C, Lillicrap D, Taylor SAM, Windsor S, Valleix SV, Nafa K, Sultan Y, Delpech M, Vnencak-Jones CL, Phillips JA, Ljung RCR, Koumbarelis E, Gialeraki A, Mandalaki T, Jenkins PV, Collins PW, Pasi KJ, Goodeve A, Peake I, Preston FE, Schwartz M, Scheibel E, Ingerslev J, Cooper DN, Millar DS, Kakkar VV, Giannelli F, Naylor JA, Tizzano EF, Baiget M, Domenech M, Altisent C, Tusell J, Beneyto M, Lorenzo JI, Gaucher C, Mazurier C, Peerlinck K, Matthijs G, Cassiman JJ, Vermylen J, Mori PG, Acquila M, Caprino D and lnaba H (1995) Factor VIII gene inversions in severe haemophilia A: results of an international consortium study. Blood 86:2206–2212PubMed
4.
go back to reference De Brasi CD, Candela M, Cermelj M, Slavutsky I, Larripa I, Bianco RP, De Tezanos Pinto M (2000) Intron 22 factor VIII gene inversions in Argentine families with severe haemophilia A. Haemophilia 6(1):21–22. doi:10.3324/haematol.11112 PubMedCrossRef De Brasi CD, Candela M, Cermelj M, Slavutsky I, Larripa I, Bianco RP, De Tezanos Pinto M (2000) Intron 22 factor VIII gene inversions in Argentine families with severe haemophilia A. Haemophilia 6(1):21–22. doi:10.​3324/​haematol.​11112 PubMedCrossRef
5.
go back to reference Naylor J, Buck D, Green PM, Williamson H, Bentley D, Giannelli F (1995) Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet 4(7):1217–1224. doi:10.1093/hmg/4.7.1217 PubMedCrossRef Naylor J, Buck D, Green PM, Williamson H, Bentley D, Giannelli F (1995) Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet 4(7):1217–1224. doi:10.​1093/​hmg/​4.​7.​1217 PubMedCrossRef
9.
go back to reference Abou-Elew H, Ahemed H, Raslan H, Abdelwahab M, Hammoud MD, Arnaout H (2011) Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients. Ann Hematol 90(5):579–584. doi:10.1007/s00277-010-1115-x PubMedCrossRef Abou-Elew H, Ahemed H, Raslan H, Abdelwahab M, Hammoud MD, Arnaout H (2011) Genotyping of intron 22-related rearrangements of F8 by inverse-shifting PCR in Egyptian hemophilia A patients. Ann Hematol 90(5):579–584. doi:10.​1007/​s00277-010-1115-x PubMedCrossRef
11.
go back to reference Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, Varadi A, Tordai Attila (2003) Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica 88(7):778–784. doi:10.1182/blood.V99.1.168 PubMed Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, Varadi A, Tordai Attila (2003) Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A. Haematologica 88(7):778–784. doi:10.​1182/​blood.​V99.​1.​168 PubMed
12.
go back to reference Windsor S, Taylor SAM, Lillicrap D (1994) Direct detection of a common inversion mutation in the genetic diagnosis of severe hemophilia A. Blood 84(7):2202–2205PubMed Windsor S, Taylor SAM, Lillicrap D (1994) Direct detection of a common inversion mutation in the genetic diagnosis of severe hemophilia A. Blood 84(7):2202–2205PubMed
13.
go back to reference Poon MC, Low S, Sinclair GD (1995) Factor VIII gene rearrangement analysis and carrier determination in hemophilia A. J Lab Clin Med 125(3):402–406PubMed Poon MC, Low S, Sinclair GD (1995) Factor VIII gene rearrangement analysis and carrier determination in hemophilia A. J Lab Clin Med 125(3):402–406PubMed
Metadata
Title
Are int22h-mediated deletions a common cause of hemophilia?
Authors
Miguel Martín Abelleyro
Liliana Carmen Rossetti
Claudia Pamela Radic
Miguel Candela
Irene Beatriz Larripa
Carlos Daniel De Brasi
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 4/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1295-z

Other articles of this Issue 4/2012

Annals of Hematology 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine